International Clinical Trial: Efficacy of Low-Dose Etoposide Combined with PEG-G-CSF for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115897) titled 'Efficacy of Low-Dose Etoposide Combined with PEG-G-CSF for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma' on Jan. 4.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The Second Affiliated Hospital of Hainan Medical University

Condition: Multiple Myeloma

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-15

Target Sample Size: Etoposide+PEG G-CSF:23;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=283044

Published by HT Digital Content Services with permission from Health Daily Digest....